We are live on ! Find out more
BKYI

BIO-key International
BKYI

6 hedge funds and large institutions have $219K invested in BIO-key International in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more capital invested

Capital invested by funds: $142K → $219K (+$76.9K)

0.71% more ownership

Funds ownership: 0.02% → 0.73% (+0.71%)

40% less funds holding

Funds holding: 10 → 6 (-4)

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

Holders
6
Holders Change
-4
Holders Change %
-40%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
–
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$285K
2
TRCT
Tower Research Capital (TRC)
New York
+$26.2K
3
Osaic Holdings
Osaic Holdings
Arizona
+$4.14K
4
Group One Trading
Group One Trading
Illinois
+$1.44K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$59.1K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$43.8K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$13.1K
4
Citadel Advisors
Citadel Advisors
Florida
-$11.1K
5
Renaissance Technologies
Renaissance Technologies
New York
-$6K

BKYI Hedge Fund Activity: Q4 2023 in Review

6 of the 6,826 institutional investors tracked by Wall St. Rank reported a position in BIO-key International (BKYI) for Q4 2023, worth a combined $219K — up 54% from $142K a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of BKYI and 3 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was Armistice Capital, opening a new position worth an estimated $285K. The largest seller was Vanguard Group, exiting entirely with an estimated $59.1K sold.

  • 6 institutional investors held BIO-key International (BKYI) as of Q4 2023, down from 10 in Q3 2023.
  • Funds reported $219K of BIO-key International stock for Q4 2023, up 54% quarter-over-quarter.
  • 3 funds opened new BIO-key International positions in Q4 2023 and 7 closed out, a net change of -4 holders.
  • The largest BIO-key International buyer in Q4 2023 was Armistice Capital, an estimated $285K added.
  • The largest BIO-key International seller in Q4 2023 was Vanguard Group, an estimated $59.1K sold.

Based on aggregated 13F filings for Q4 2023.